Arjuna Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.33M Sell
4,447
-39
-0.9% -$39.8K 1.2% 18
2026
Q1
$4.13M Buy
4,486
+222
+5% +$225K 1.05% 21
2025
Q4
$4.58M Sell
4,264
-232
-5% -$222K 1.12% 17
2025
Q3
$3.43M Buy
4,496
+3,886
+637% +$2.89M 0.85% 28
2025
Q2
$476K Buy
+610
New +$474K 0.13% 93

Other funds holding LLY

Arjuna Capital's LLY Position: Q2 2026 in Review

Arjuna Capital reduced its Eli Lilly (LLY) stake by 0.87% in Q2 2026, selling an estimated $39.8K and leaving 4,447 shares worth $5.33M. The position accounts for 1.2% of the portfolio, ranked #18.

Arjuna Capital first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Arjuna Capital held 4,447 shares of Eli Lilly worth $5.33M as of Q2 2026.
  • Arjuna Capital sold 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 1.2% of Arjuna Capital's portfolio in Q2 2026, its #18 holding.
  • Arjuna Capital first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arjuna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.